ArticleBMC oral health2025
Attitude and practice of dentists in patients taking oral antiplatelet and anticoagulant medications.
Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Development of ready-to-use tranexamic acid gauze as a hemostatic material for oral surgery: fabrication, hemostasis, and shelf-life.BMC oral health · 2026Article
- Local Hemostasis as the Critical Enabler for Safe Antithrombotic Therapy in Dentistry-Navigating Future Frontiers and Innovative Concepts.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeIn everyday practice, dentists are confronted with the dilemma of patients on antiplatelet and anticoagulant agents who require dental procedures.The present survey aimed to exhibit Turkish dentists' awareness and attitude towards patients using blood thinners prior to dental procedures and point out the significance of this issue.
methodsAn electronic survey was administered to dental practitioners. Demographics, career details, answerbacks to medical consultation and agents consisting of 20-questions investigating approaches to patients using antiplatelet and anticoagulant agents were recorded.Data were collected in the online platform and analyzed.
resultsA total of 500 dentists answered the survey, of which 48.2% were female and 51.8% were male. %57.8 of all respondents inaccurately marked warfarin as an antiplatelet agent. In patients who underwent coronary stent implantation,24.6% of dentists unfortunately stated that they always discontinue the actual medications before surgery. The majority of cardiology consultants interrupted the drug 5-7 days before the intervention in patients receiving antiplatelet therapy.16.6% of consultants made a decision based on international normalized ratio (INR) level of the patients using direct oral anticoagulant (DOAC).
conclusionAlthough dental procedures do not posses a high bleeding risk and can be safely performed without interruption of blood thinners, there is an overestimation of the risk of bleeding by the dentists.It's understood that a considerable number of participants are not familiar with the blood thinners, coagulation tests and perioperative management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.